お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:心房細動 (AF) 治療市場 - 市場規模、シェア、見通し、機会分析:2020年~2027年
市場調査レポート
商品コード
959459

心房細動 (AF) 治療市場 - 市場規模、シェア、見通し、機会分析:2020年~2027年

Atrial Fibrillation Market, By Procedure (Pharmacological, Non-Pharmacological ), and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版日: | 発行: Coherent Market Insights | ページ情報: 英文 140 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=109.05円
心房細動 (AF) 治療市場 - 市場規模、シェア、見通し、機会分析:2020年~2027年
出版日: 2020年09月01日
発行: Coherent Market Insights
ページ情報: 英文 140 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 目次
概要

心房細動 (AF) は、心臓の電気システムの障害によって引き起こされる異常な心調律によって区別される心臓の不整脈の一種です。予測期間中は、製品承認の増加に加え、心房細動の高い有病率が、市場の成長を促進すると予想されます。

当レポートでは、世界の心房細動 (AF) 治療市場について調査分析し、市場概要、市場規模と予測、セグメント別の市場分析、地域別の市場分析、競合情勢などについて、体系的な情報を提供しています。

目次

第1章 調査目的と前提条件

第2章 市場の範囲

第3章 市場力学・規制・動向分析

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • 影響分析
  • 主なハイライト
  • 製品発売
  • PEST分析
  • 技術の進歩
  • 規制シナリオ
  • M&A

第4章 世界の心房細動 (AF) 治療市場:処置別

  • イントロダクション
  • 薬理学的
  • 非薬理学的

第5章 世界の心房細動 (AF) 治療市場:地域別

  • イントロダクション
  • 北米
  • ラテンアメリカ
  • 欧州
  • アジア太平洋
  • 中東
  • アフリカ

第6章 競合情勢

  • 企業プロファイル
    • AtriCure, Inc.
    • Biosense Webster, Inc.
    • Boehringer Ingelheim GmbH
    • Boston Scientific Corporation
    • Bristol-Myers Squibb Corporation
    • CardioFocus, Inc.
    • Endoscopic Technologies, Inc.
    • Sanofi Aventis
    • Johnson and Johnson Ltd.
    • Abbott Laboratories

第7章 セクション

目次

Title:
Atrial Fibrillation Market, By Procedure (Pharmacological (Anti-arrhythmic, Anti-coagulant), Non-Pharmacological (Catheter Ablation Procedures, Maze surgery, Electric Cardioversion)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & AFrica) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Atrial Fibrillation is also known as A-fib or AF, is an irregular heartbeat exemplified by rapid and abnormal beating of the heart. It is linked with an elevated risk of heart failure, stroke, and dementia. Atrial fibrillation is a type of cardiac arrhythmia distinguished by an abnormal cardiac rhythm caused by a disturbance in heart's electrical system. High prevalence of atrial fibrillation along with increasing product approvals during the forecasted period is expected to assist the growth of the market. Furthermore, major players in the global atrial fibrillation market are focused on R&D to expand their product portfolio which is also expected to drive the market during the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the Global Atrial Fibrillation market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2020-2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Global Atrial Fibrillation market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, AtriCure, Inc., Biosense Webster, Inc., Boehringer Ingelheim GmbH, Boston Scientific Corporation, Bristol-Myers Squibb Corporation, CardioFocus, Inc., Endoscopic Technologies, Inc., Sanofi Aventis, Inc., Johnson and Johnson Ltd., and Abbott Laboratories.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Global Atrial Fibrillation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Atrial Fibrillation market

Detailed Segmentation:

  • Global Atrial Fibrillation Market, By Procedure:
    • Pharmacological
    • Anti-arrhythmic
    • Anti-coagulant
    • Non-Pharmacological
    • Catheter Ablation Procedures
    • Maze surgery
    • Electric Cardioversion
  • Global Atrial Fibrillation Market, By Region:
  • North America
    • By Procedure:
    • Pharmacological
    • Anti-arrhythmic
    • Anti-coagulant
    • Non-Pharmacological
    • Catheter Ablation Procedures
    • Maze surgery
    • Electric Cardioversion
    • By Country
    • U.S.
    • Canada
  • Latin America
    • By Procedure:
    • Pharmacological
    • Anti-arrhythmic
    • Anti-coagulant
    • Non-Pharmacological
    • Catheter Ablation Procedures
    • Maze surgery
    • Electric Cardioversion
    • By Country
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • By Procedure:
    • Pharmacological
    • Anti-arrhythmic
    • Anti-coagulant
    • Non-Pharmacological
    • Catheter Ablation Procedures
    • Maze surgery
    • Electric Cardioversion
    • By Country
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • By Procedure:
    • Pharmacological
    • Anti-arrhythmic
    • Anti-coagulant
    • Non-Pharmacological
    • Catheter Ablation Procedures
    • Maze surgery
    • Electric Cardioversion
    • By Country
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • By Procedure:
    • Pharmacological
    • Anti-arrhythmic
    • Anti-coagulant
    • Non-Pharmacological
    • Catheter Ablation Procedures
    • Maze surgery
    • Electric Cardioversion s
    • By Country
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • By Procedure:
    • Pharmacological
    • Anti-arrhythmic
    • Anti-coagulant
    • Non-Pharmacological
    • Catheter Ablation Procedures
    • Maze surgery
    • Electric Cardioversion
    • By Country
    • North Africa
    • Central Africa
    • South Africa
  • Company Profiles
  • AtriCure, Inc. *
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Biosense Webster, Inc.
  • Boehringer Ingelheim GmbH
  • Boston Scientific Corporation
  • Bristol-Myers Squibb Corporation
  • CardioFocus, Inc.
  • Endoscopic Technologies, Inc.
  • Sanofi Aventis, Inc.
  • Johnson and Johnson Ltd.
  • Abbott Laboratories
  • "*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Procedure
    • Market Snippet, By Country
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • Product launch
  • PEST Analysis
  • Technological Advancements
  • Regulatory Scenario
  • Mergers and Acquisitions

4. Global Atrial Fibrillation Market, By Procedure, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Pharmacological
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Anti-arrhythmic
    • Anti-coagulant
  • Non-Pharmacological
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Catheter Ablation Procedures
    • Maze surgery
    • Electric Cardioversion

5. Global Atrial Fibrillation Market, By Region, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
    • Market Size and Forecast, By Procedure, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Procedure, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Procedure, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Procedure, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Procedure, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Procedure, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

6. Competitive Landscape

  • Company Profiles
    • AtriCure, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Biosense Webster, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Boehringer Ingelheim GmbH
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Boston Scientific Corporation
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Bristol-Myers Squibb Corporation
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • CardioFocus, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Endoscopic Technologies, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sanofi Aventis
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Johnson and Johnson Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

7. Section

  • References
  • Research Methodology
  • About us and Sales Contact
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.